There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

According to a new report by the US National Security Commission on Emerging Biotechnology, China’s systematic state-driven ...

China trade tensions, AdAlta aims to be a gateway for Asia's next wave of cellular immunotherapies to enter ... Read More The ...

Last month, Lilly's newly opened Lilly Gateway Labs in Beijing welcomed its first tenant, namely a Chinese biotechnology company focusing on innovative medicines for neurodegenerative and ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

The global expansion of Chinese biotech companies accelerated in the first quarter, with the number of overseas deals surging 18 per cent year on year, showing strong momentum in the field of ...

Capital is following suit, with dollars pouring into Chinese biotech assets, responding to a regulatory environment that’s more permissive of experimentation and progress. This is not theoretical.

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

The China Biotechnology Directory 2025 is an indispensable resource for navigating the fast-growing Chinese biotech market. With thousands of up-to-date company profiles, executive contacts, and ...

Akeso's drug sales rose 25% last year to just above 2 billion yuan, setting a new high for the company A potential launch for the company's ivonescimab in the U.S. next year could bring it big new ...